Overview

Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma

Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
BDNF has been linked to the pathogenesis of airway hyperresponsiveness in asthma. In this trial, the impact of a treatment with salmeterol and salmeterol / fluticasone on BDNF concentrations will be assessed in patients with asthma. The investigators hypothesize that salmeterol impacts on BDNF concentrations in patients with asthma.
Phase:
N/A
Details
Lead Sponsor:
University of Rostock
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone
Salmeterol Xinafoate